Company intelligence / Profile preview

BioPoly

Fort Wayne, Indiana, USAbiopolyortho.com ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

BioPoly has demonstrated positive 2-year and 5-year clinical results for its partial resurfacing implants in Europe. The U.S. pivotal trial for the Partial Resurfacing Knee Implant is ongoing to demonstrate safety and effectiveness compared to standard surgical interventions.

Therapeutic areas: Rheumatology
Modalities: DeviceBiomaterial implant (specifically, a proprietary blend of hyaluronic acid and polyethylene)
Industry: Implantable Medical Devices

Drug pipeline

4 assets

BioPoly Knee Implant

Commercial

Indications: Knee cartilage defects

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on BioPoly.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioPoly.

Explore the full profile